Sigma Solvents And Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 7.50 M
as on 17-12-2024
- Paid Up Capital ₹ 1.50 M
as on 17-12-2024
- Company Age 34 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 1.88 Cr
as on 17-12-2024
- Revenue 96.48%
(FY 2023)
- Profit 63.88%
(FY 2023)
- Ebitda 575.03%
(FY 2023)
- Net Worth 9.89%
(FY 2023)
- Total Assets -0.56%
(FY 2023)
About Sigma Solvents And Pharmaceuticals
The Company is engaged in the Manufacturing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 7.50 M and a paid-up capital of Rs 1.50 M.
The company has closed loans amounting to ₹1.88 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Jitendra Doshi, Ketan Gandhi, and Harshadbhai Shah serve as directors at the Company.
- CIN/LLPIN
U24232GJ1990PLC013908
- Company No.
013908
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
21 Jun 1990
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Mahesana, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Sigma Solvents And Pharmaceuticals?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jitendra Doshi  | Director | 01-Sep-2008 | Current |
| Ketan Gandhi | Director | 01-Sep-1997 | Current |
| Harshadbhai Shah | Director | 01-Sep-1997 | Current |
Financial of Sigma Solvents And Pharmaceuticals.
Sigma Solvents And Pharmaceuticals Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 96.48% increase. The company also saw a substantial improvement in profitability, with a 63.88% increase in profit. The company's net worth moved up by a moderate rise of 9.89%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sigma Solvents And Pharmaceuticals?
In 2023, Sigma Solvents And Pharmaceuticals had a promoter holding of 52.73% and a public holding of 47.27%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Doshi Chemicals Pvt LtdActive 37 years 3 monthsJitendra Doshi and Harshadbhai Shah are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Syndicate Bank Creation Date: 22 Jul 2014 | ₹1.80 M | Satisfied |
The Madhavpura Mercantile Co-Op. Bank Ltd. Creation Date: 18 Oct 2000 | ₹1.20 Cr | Satisfied |
The Madhavpura Mercantile Co-Op. Bank Ltd. Creation Date: 23 Feb 1999 | ₹5.00 M | Satisfied |
How Many Employees Work at Sigma Solvents And Pharmaceuticals?
Unlock and access historical data on people associated with Sigma Solvents And Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sigma Solvents And Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sigma Solvents And Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
